Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

Garcia, F (author)

de Quiros, JCLB (author)

Gomez, CE (author)

show more...

Perdiguero, B (author)

Najera, JL (author)

Jimenez, V (author)

Garcia-Arriaza, J (author)

Guardo, AC (author)

Perez, I (author)

Diaz-Brito, V (author)

Conde, MS (author)

Gonzalez, N (author)

Alvarez, A (author)

Alcami, J (author)

Jimenez, JL (author)

Pich, J (author)

Arnaiz, JA (author)

Maleno, MJ (author)

Leon, A (author)

Munoz-Fernandez, MA (author)

Liljestrom, P (author)

Karolinska Institutet

Weber, J (author)

Pantaleo, G (author)

Gatell, JM (author)

Plana, M (author)

Esteban, M (author)

show less...

 (creator_code:org_t)

Elsevier BV, 2011

2011

English.

In: Vaccine. - : Elsevier BV. - 1873-2518 .- 0264-410X. ; 29:46, s. 8309-8316

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)